OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

MRUS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Merus (MRUS) Earnings Date & Reports

Merus NV is a clinical-stage immuno-oncology company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MRUS is expected to report earnings to fall 18.57% to -113 cents per share on July 31

Q2'25

Est.

$-1.14

Q1'25

Missed

by $0.29

Q4'24

Beat

by $0.48

Q3'24

Missed

by $0.60

Q2'24

Missed

by $0.05

The last earnings report on May 07 showed earnings per share of -139 cents, missing the estimate of -111 cents. With 113.82K shares outstanding, the current market capitalization sits at 3.95B.

View a ticker or compare two or three

Compare

MRUS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For MRUS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

View to see Real Time Patterns for MRUS (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of therapeutics for cancer treatment

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

Uppsalalaan 17

Phone

+31 302538800

Employees

229

Web

https://www.merus.nl